ロード中...
Effects of Verapamil and Diltiazem on the Pharmacokinetics and Pharmacodynamics of Rivaroxaban
Concomitant use of rivaroxaban with non-dihydropyridine calcium channel blockers (non-DHPs) might lead to an increase of systemic rivaroxaban exposure and anticoagulant effects in relation to the inhibition of metabolic enzymes and/or transporters by non-DHPs. This study was designed to evaluate the...
保存先:
| 出版年: | Pharmaceutics |
|---|---|
| 主要な著者: | , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
MDPI
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6470838/ https://ncbi.nlm.nih.gov/pubmed/30893910 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/pharmaceutics11030133 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|